Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1828 1
1891 1
1912 1
1913 1
1928 1
1937 1
1946 2
1947 3
1948 5
1949 4
1950 3
1951 2
1952 3
1953 2
1954 4
1955 1
1958 2
1959 4
1960 2
1961 1
1962 7
1963 4
1964 9
1965 4
1966 2
1967 6
1968 2
1969 2
1970 3
1971 7
1972 10
1973 10
1974 11
1975 9
1976 12
1977 12
1978 15
1979 12
1980 13
1981 17
1982 20
1983 13
1984 14
1985 13
1986 9
1987 14
1988 23
1989 20
1990 14
1991 30
1992 21
1993 33
1994 39
1995 30
1996 49
1997 31
1998 37
1999 37
2000 46
2001 48
2002 29
2003 51
2004 47
2005 46
2006 57
2007 44
2008 43
2009 46
2010 72
2011 81
2012 115
2013 109
2014 118
2015 158
2016 185
2017 154
2018 188
2019 179
2020 175
2021 166
2022 148
2023 140
2024 79

Text availability

Article attribute

Article type

Publication date

Search Results

2,907 results

Results by year

Filters applied: . Clear all
Page 1
Autism Spectrum Disorder: A Review.
Hirota T, King BH. Hirota T, et al. Among authors: king bh. JAMA. 2023 Jan 10;329(2):157-168. doi: 10.1001/jama.2022.23661. JAMA. 2023. PMID: 36625807 Review.
Medical Treatment of Benign Prostatic Hyperplasia.
Plochocki A, King B. Plochocki A, et al. Among authors: king b. Urol Clin North Am. 2022 May;49(2):231-238. doi: 10.1016/j.ucl.2021.12.003. Epub 2022 Mar 22. Urol Clin North Am. 2022. PMID: 35428429 Review.
Janus kinase inhibitors for alopecia areata.
King BA, Craiglow BG. King BA, et al. J Am Acad Dermatol. 2023 Aug;89(2S):S29-S32. doi: 10.1016/j.jaad.2023.05.049. J Am Acad Dermatol. 2023. PMID: 37591562 Review.
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial.
King B, Zhang X, Harcha WG, Szepietowski JC, Shapiro J, Lynde C, Mesinkovska NA, Zwillich SH, Napatalung L, Wajsbrot D, Fayyad R, Freyman A, Mitra D, Purohit V, Sinclair R, Wolk R. King B, et al. Lancet. 2023 May 6;401(10387):1518-1529. doi: 10.1016/S0140-6736(23)00222-2. Epub 2023 Apr 14. Lancet. 2023. PMID: 37062298 Clinical Trial.
Consensus Recommendations for Radiation Therapy Contouring and Treatment of Vulvar Carcinoma.
Gaffney DK, King B, Viswanathan AN, Barkati M, Beriwal S, Eifel P, Erickson B, Fyles A, Goulart J, Harkenrider M, Jhingran A, Klopp A, Koh WJ, Lim K, Petersen I, Portelance L, Small W Jr, Stewart A, Wiebe E, Wolfson A, Yashar C, Bosch W. Gaffney DK, et al. Among authors: king b. Int J Radiat Oncol Biol Phys. 2016 Jul 15;95(4):1191-200. doi: 10.1016/j.ijrobp.2016.02.043. Epub 2016 Feb 21. Int J Radiat Oncol Biol Phys. 2016. PMID: 27130794 Free PMC article.
Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trial.
Ezzedine K, Peeva E, Yamaguchi Y, Cox LA, Banerjee A, Han G, Hamzavi I, Ganesan AK, Picardo M, Thaçi D, Harris JE, Bae JM, Tsukamoto K, Sinclair R, Pandya AG, Sloan A, Yu D, Gandhi K, Vincent MS, King B. Ezzedine K, et al. Among authors: king b. J Am Acad Dermatol. 2023 Feb;88(2):395-403. doi: 10.1016/j.jaad.2022.11.005. Epub 2022 Nov 9. J Am Acad Dermatol. 2023. PMID: 36370907 Free article. Clinical Trial.
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2).
Kwon O, Senna MM, Sinclair R, Ito T, Dutronc Y, Lin CY, Yu G, Chiasserini C, McCollam J, Wu WS, King B. Kwon O, et al. Among authors: king b. Am J Clin Dermatol. 2023 May;24(3):443-451. doi: 10.1007/s40257-023-00764-w. Epub 2023 Mar 1. Am J Clin Dermatol. 2023. PMID: 36855020 Free PMC article. Clinical Trial.
Cellular adaptation to cancer therapy along a resistance continuum.
França GS, Baron M, King BR, Bossowski JP, Bjornberg A, Pour M, Rao A, Patel AS, Misirlioglu S, Barkley D, Tang KH, Dolgalev I, Liberman DA, Avital G, Kuperwaser F, Chiodin M, Levine DA, Papagiannakopoulos T, Marusyk A, Lionnet T, Yanai I. França GS, et al. Among authors: king br. Nature. 2024 Jul;631(8022):876-883. doi: 10.1038/s41586-024-07690-9. Epub 2024 Jul 10. Nature. 2024. PMID: 38987605
A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results.
King B, Guttman-Yassky E, Peeva E, Banerjee A, Sinclair R, Pavel AB, Zhu L, Cox LA, Craiglow B, Chen L, Banfield C, Page K, Zhang W, Vincent MS. King B, et al. J Am Acad Dermatol. 2021 Aug;85(2):379-387. doi: 10.1016/j.jaad.2021.03.050. Epub 2021 Mar 20. J Am Acad Dermatol. 2021. PMID: 33757798 Free article. Clinical Trial.
2,907 results